- Sector
- Healthcare
- Industry
- Medical Distribution
Highlights
- Market Cap
- $245.44M
- Enterprise Value
- $1.14B
- EPS (TTM)
- -$14.29
- Total Revenue (TTM)
- $2.72B
- Gross Profit (TTM)
- $937.09M
- EBITDA (TTM)
- $192.32M
- Year Range
- $1.84 - $9.55
- Target Price
- $4.00
- ROA (TTM)
- -45.50%
- ROE (TTM)
- 236.51%
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
ACH Performance Chart
Accendra Health, Inc (ACH) is up 14.3% since the beginning of the year. At $3 per share, ACH is trading 66.5% below its 52-week high of $10. Investors who bought $1,000 worth of ACH shares 5 years ago would now be looking at an investment worth $76.
Loading charts...
Returns By Period
Accendra Health, Inc (ACH) has returned 14.29% so far this year and -56.40% over the past 12 months. Over the last ten years, ACH has returned -20.83% per year, falling short of the S&P 500 Index benchmark, which averaged 13.88% annually.
Accendra Health, Inc
- 1D
- -0.93%
- 1M
- 13.07%
- YTD
- 14.29%
- 6M
- 19.40%
- 1Y
- -56.40%
- 3Y*
- -44.42%
- 5Y*
- -40.21%
- 10Y*
- -20.83%
Benchmark (S&P 500 Index)
- 1D
- -0.37%
- 1M
- -0.01%
- YTD
- 9.16%
- 6M
- 8.64%
- 1Y
- 25.22%
- 3Y*
- 19.78%
- 5Y*
- 11.99%
- 10Y*
- 13.88%
ACH Monthly Returns History
Based on dividend-adjusted daily data since Dec 16, 1988, ACH's average daily return is +0.05%, while the average monthly return is +1.04%. At this rate, an investment would double in approximately 5.6 years.
Historically, 52% of months were positive and 48% were negative. The best month was Jul 2020 with a return of +111.0%, while the worst month was Oct 2018 at -52.2%. The longest winning streak lasted 9 consecutive months, and the longest losing streak was 6 months.
On a daily basis, ACH closed higher 47% of trading days. The best single day was Jul 21, 2020 with a return of +81.4%, while the worst single day was Oct 31, 2018 at -44.4%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -21.07% | 9.50% | -5.79% | 62.72% | -23.45% | 12.68% | 14.29% | ||||||
| 2025 | 8.95% | -32.72% | -5.74% | -21.82% | -6.52% | 37.88% | -23.85% | -29.29% | -2.04% | -17.29% | -31.49% | 2.94% | -78.58% |
| 2024 | 2.28% | 23.44% | 13.89% | -10.72% | -29.55% | -22.55% | 21.63% | -5.36% | 0.97% | -18.99% | 5.98% | -2.97% | -32.17% |
| 2023 | 1.08% | -22.34% | -5.09% | 6.80% | 30.69% | -6.25% | 1.05% | -12.16% | -4.38% | -11.32% | 38.73% | -3.07% | -1.33% |
| 2022 | -3.24% | 4.89% | -0.29% | -19.38% | -1.72% | -9.83% | 12.59% | -16.66% | -18.33% | -29.46% | 21.24% | -5.24% | -55.10% |
| 2021 | 7.50% | 16.95% | 10.53% | -3.99% | 23.88% | -5.32% | 9.26% | -19.39% | -16.06% | 14.67% | 11.48% | 8.76% | 60.85% |
Benchmark Metrics
Accendra Health, Inc has an annualized alpha of 6.35%, beta of 0.72, and R2 of 0.07 versus S&P 500 Index. Calculated based on daily prices since December 16, 1988.
- This stock participated in 72.03% of S&P 500 Index downside but only 47.38% of its upside - more exposed to losses than it benefited from rallies.
- R2 of 0.07 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- 6.35%
- Beta
- 0.72
- R²
- 0.07
- Upside Capture
- 47.38%
- Downside Capture
- 72.03%
Return for Risk
Risk / Return Rank
ACH ranks 17 for risk / return — in the bottom 17% of stocks on our site. This means you're taking on significantly more risk than the returns justify. Consider whether the potential upside is worth the volatility, or explore alternatives with better risk / return profiles.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for Accendra Health, Inc (ACH) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| ACH | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.68 | ||
| Sortino ratioReturn per unit of downside risk | -3.40 | ||
| Omega ratioGain probability vs. loss probability | 0.91 | 1.37 | -0.45 |
| Calmar ratioReturn relative to maximum drawdown | -0.71 | 2.78 | -3.49 |
| Martin ratioReturn relative to average drawdown | -0.92 | 12.44 | -13.36 |
Dividends
Dividend History
Accendra Health, Inc provided a 0.00% dividend yield over the last twelve months, with an annual payout of $0.00 per share.
| Period | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.01 | $0.01 | $0.01 | $0.86 | $1.03 | $1.02 | $1.01 |
Dividend yield | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.02% | 0.04% | 0.19% | 13.51% | 5.46% | 2.89% | 2.81% |
Monthly Dividends
The table displays the monthly dividend distributions for Accendra Health, Inc. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||
| 2025 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2024 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2023 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2022 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2021 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.01 |
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Accendra Health, Inc. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Accendra Health, Inc was 96.08%, occurring on Jan 6, 2026. The portfolio has not yet recovered.
The current Accendra Health, Inc drawdown is 93.43%.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
2026 bear market2026 | -96.08%Jan 2026 | 4y 7mo | — | 5y 15dJun 2021 - now |
2019 bear market2019 | -93.26%Jul 2019 | 3y 3mo | 1y 7mo | 4y 10moApr 2016 - Mar 2021 |
1999 bear market1999 | -58.84%Nov 1999 | 1y 7mo | 1y 5mo | 3y 1moMar 1998 - Apr 2001 |
1996 bear market1996 | -46.82%Sep 1996 | 2y 6mo | 1y 4mo | 3y 11moMar 1994 - Feb 1998 |
Financial crisis2007–2009 | -37.16%Mar 2009 | 7mo 24d | 1y 28d | 1y 8moJul 2008 - Apr 2010 |
Drawdown Indicators
| ACH | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -96.08% | -56.78% | -39.30% |
Max Drawdown (1Y)Largest decline over 1 year | -79.72% | -9.10% | -70.62% |
Max Drawdown (3Y)Largest decline over 3 years | -93.17% | -18.90% | -74.27% |
Max Drawdown (5Y)Largest decline over 5 years | -96.00% | -25.43% | -70.57% |
Max Drawdown (10Y)Largest decline over 10 years | -96.08% | -33.92% | -62.16% |
Current DrawdownCurrent decline from peak | -93.43% | -1.80% | -91.63% |
Average DrawdownAverage peak-to-trough decline | -25.52% | -10.71% | -14.81% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 61.01% | 2.03% | +58.98% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Accendra Health, Inc over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Accendra Health, Inc is priced in the market compared to other companies in the Medical Distribution industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for ACH relative to other companies in the Medical Distribution industry. Currently, ACH has a P/S ratio of 0.1. This P/S ratio is low compared to the industry average. It may indicate that the stock is undervalued relative to its revenue, or that the market expects slower growth or lower margins.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with ACH
Add Accendra Health, Inc to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with ACH